EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor

Bryan Berube, Aditi Deshpande, Amala Bhagwat, Tanya Parish

Microbiology · 2023

DOI: 10.1099/mic.0.001345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology, 2023. Verfasst von Bryan Berube und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indolcarboxamides are a promising series of anti-tubercular agents, which target Mycobacterium tuberculosis MmpL3, the exporter of trehalose monomycolate, a key cell-wall component. We determined the kill kinetics of the lead indolcarboxamide NITD-349 and determined that while kill was rapid against low-density cultures, bactericidal activity was inoculum-dependent. A combination of NITD-349 with isoniazid (which inhibits mycolate synthesis) had an increased kill rate; this combination prevented the appearance of resistant mutants, even at higher inocula.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsMembrane Transport ProteinsBacterial ProteinsIsoniazidMicrobial Sensitivity Tests

Stichwörter der Autor:innen

anti-tubercularbactericidal activitycell-wall inhibitortuberculosis drug discovery

Substanzen

Antitubercular AgentsMembrane Transport ProteinsBacterial ProteinsIsoniazid

Autor:innen und Institutionen

  • Center for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA.
  • TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA.
  • Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • Bill and Melinda Gates Foundation

Zitieren

APA

Berube, B., Deshpande, A., Bhagwat, A., & Parish, T. (2023). Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor. Microbiology. https://doi.org/10.1099/mic.0.001345

Vancouver

Berube B, Deshpande A, Bhagwat A, Parish T. Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor. Microbiology. 2023. doi:10.1099/mic.0.001345

BibTeX
@article{Berube2023,
  author = {Berube, Bryan and Deshpande, Aditi and Bhagwat, Amala and Parish, Tanya},
  title = {Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor},
  journal = {Microbiology},
  year = {2023},
  doi = {10.1099/mic.0.001345}
}
Kostenlos starten →